LBL-049

N/A

Report date: 2024/05/16 17:32:08

Base Information

Drug NameLBL-049
Drug Alias NameLBL-049
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionGrowth/differentiation factor 15 modulators
TargetsGrowth/differentiation factor 15
Therapy Area/IndicationsCachexiaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNanjing Leadsbiolabs Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNanjing Leadsbiolabs Co Ltd
Inactive CompaniesN/A
Active IndicationsCachexiaNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A